Datasheet

Bifidobacterium bifidum; Intestine (CAT#: LBST-052FG)

Bifidobacterium bifidum is a Gram-positive, anaerobic bacterium that is neither motile nor spore-forming. The bacterium is rod-shaped and can be found living in clusters, pairs, or even independently. It is an essential bacteria found in the human intestine.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

CAT Size Price Quantity  
LBST-052FG
Product Information
Product Overview Bifidobacterium bifidum is a Gram-positive, anaerobic bacterium that is neither motile nor spore-forming. The bacterium is rod-shaped and can be found living in clusters, pairs, or even independently. It is an essential bacteria found in the human intestine.
Target Bifidobacterium
Genus Bifidobacterium
Strain Designation 212A
Application Study and research
Type Strain No
Culture Medium BBL
Culture Conditions 37°C; Anaerobic
Risk Group 1
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction Bifidobacterium are Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They are originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS; Generally Recognised As Safe status.
Alternative Names Bifidobacterium bifidum; 11863
FAQs Published Data Customer Reviews Related Products
  1. What are the optimal growth conditions for Bifidobacterium bifidum in laboratory settings?

    The optimal growth conditions typically include anaerobic environments supplemented with specific growth media tailored for Bifidobacterium species. For more detailed protocols, refer to scientific literature on microbiological cultivation methods.

  2. How can Bifidobacterium bifidum be preserved for long-term storage in research laboratories?

    Bifidobacterium bifidum can be stored at ultra-low temperatures (-80°C) or in specialized cryopreservation solutions to maintain viability and functionality over extended periods.

  3. What are the primary applications of Bifidobacterium bifidum in scientific research?

    Bifidobacterium bifidum is extensively studied for its potential in gastrointestinal health, immune modulation, and probiotic therapy. Research focuses include its effects on gut microbiota composition, inflammation modulation, and therapeutic applications in gastrointestinal disorders.

  4. What molecular tools or techniques are commonly used to study Bifidobacterium bifidum in research experiments?

    Molecular techniques such as PCR (Polymerase Chain Reaction), metagenomics, and transcriptomics are frequently employed to analyze gene expression, microbial community dynamics, and functional pathways influenced by Bifidobacterium bifidum in experimental models.

  5. Are there specific animal models or In vitro assays recommended for studying the therapeutic potential of Bifidobacterium bifidum?

    Animal models like rodent models of colitis or In vitro assays mimicking gut conditions are commonly used to assess the efficacy of Bifidobacterium bifidum in modulating immune responses, intestinal barrier function, and disease outcomes.

Bifidobacterium-bifidum-1863-1


Gel Electrophoresis of Lactobacillus acidophilus and Bifidobacterium bifidum gene amplification

The research explores the application of Bifidobacterium bifidum; 11863 in pharmaceutical research, emphasizing its significance through experimental data. The study investigates the probiotic's potential therapeutic benefits, particularly in enhancing gastrointestinal health and modulating immune responses. Experimental findings highlight its ability to regulate gut microbiota composition, demonstrating reduced inflammation and improved intestinal barrier function in animal models. Moreover, the research underscores Bifidobacterium bifidum; 11863's role in mitigating symptoms associated with inflammatory bowel diseases, such as colitis, through its anti-inflammatory properties and promotion of mucosal integrity. These findings suggest promising avenues for developing novel therapeutic strategies harnessing probiotics to target gastrointestinal disorders effectively, thereby advancing clinical applications in digestive health and immune modulation.

Ashour, Zeinab, et al. "Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load." Gut Pathogens 14.1 (2022): 25. Distributed under Open Access license CC BY 4.0, without modification.

  • Effective for Modulating Gut Microbiota
    Creative Biolabs' Bifidobacterium bifidum; 11863 has proven effective in modulating gut microbiota composition, essential for our research in gastrointestinal health.
  • Superior Performance in Immune Modulation
    Compared to other products, Bifidobacterium bifidum; 11863 shows superior performance in immune modulation studies, crucial for advancing drug development.
  • Preferred Choice for Probiotic Research
    Creative Biolabs' Bifidobacterium bifidum; 11863 is our preferred choice for probiotic research due to its robust performance and reliable experimental outcomes.
  • Enhances Therapeutic Potential
    We have seen how Bifidobacterium bifidum; 11863 strain enhances the therapeutic potential of our drug development efforts, surpassing expectations.
  • Reliable and Consistent Quality
    The consistent quality of Bifidobacterium bifidum; 11863 from Creative Biolabs ensures reliable outcomes in our microbiome research projects.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket
Advertisement